FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Proteoderm

Sort
E.g., 2013-05-26
E.g., 2013-05-26
Enter a comma separated list of user names.

Proteonomix (PROT.OB) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on the Company's addition to its Board of Directors. Proteonomix, Inc. is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors.

Proteonomix, Inc. (PROT.OB) recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

International Business Machines Corp. (NYSE:IBM) and Universiti Brunei Darussalam (UBD) previously announced an agreement to collaborate on climate modeling research that will investigate the impact of climate change on flood forecasting, crop yields, renewable energy and the health of rainforests in the region.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT previously announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

International Business Machines Corp. (NYSE:IBM) and Universiti Brunei Darussalam (UBD) previously announced an agreement to collaborate on climate modeling research that will investigate the impact of climate change on flood forecasting, crop yields, renewable energy and the health of rainforests in the region.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT previously announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Pages

ADVERTISE WITH US